Exploring the effectiveness of persuasive games for disease prevention and awareness and the impact of tailoring to the stages of change

被引:10
|
作者
Mulchandani, Dinesh [1 ]
Alslaity, Alaa [1 ]
Orji, Rita [1 ]
机构
[1] Dalhousie Univ, Fac Comp Sci, Halifax, NS, Canada
来源
HUMAN-COMPUTER INTERACTION | 2023年 / 38卷 / 5-6期
基金
加拿大自然科学与工程研究理事会;
关键词
Persuasive games; persuasive strategies; behavior change; behavior change systems; stages of change; motivation; tailoring; personalization; gamification; COVID; covid-19; health; Games; TRANSTHEORETICAL MODEL; BEHAVIOR-CHANGE; ARCS MODEL; DESIGN; PROMOTE; STRESS;
D O I
10.1080/07370024.2022.2057858
中图分类号
TP3 [计算技术、计算机技术];
学科分类号
0812 ;
摘要
Persuasive games are widely implemented in the healthcare domain to promote behaviour change among individuals. Previous research shows that using persuasive games increases motivation and awareness, leading to a positive change in behaviour. However, there is little knowledge on which persuasive strategies will motivate people at different Stages of Behaviour Change and whether tailoring persuasive games to match users’ stages of change will increase their effectiveness with respect to their motivational appeal towards promoting disease awareness and prevention using the ARCS motivation scales and their intention to adopt the precautionary measures. To address this gap, using COVID-19 as a case study, we designed two different versions of a persuasive game, called COVID Pacman, using different persuasive strategies. The two versions of the game target the same goal of motivating the adoption of precautionary measures. We conducted a quantitative study (N=127) followed by semi-structured interviews of 18 participants. The results of conducting an ANOVA on the quantitative data and thematic analysis on the qualitative study show that tailoring the persuasive games to individual’s stages of change by using appropriate persuasive strategies increased their effectiveness with respect to their ability to motivate people to adopt the precautionary measures towards disease prevention compared to the non-tailored version. © 2022 Taylor & Francis Group, LLC.
引用
收藏
页码:459 / 494
页数:36
相关论文
共 36 条
  • [31] Daily almond consumption in cardiovascular disease prevention via LDL-C change in the U.S. population: a cost-effectiveness analysis
    Jifan Wang
    Michelle A. Lee Bravatti
    Elizabeth J. Johnson
    Gowri Raman
    BMC Public Health, 20
  • [32] Impact of the Coronavirus Disease 2019 [COVID-19] Pandemic on Post-Acute Care of Patients with Heart Failure and the Effectiveness of Vaccine Prevention
    Chang, Lin-Yuan
    Chao, Chin-Yi
    Huang, Jin-Long
    Chen, Yun-Yu
    Wang, Chi-Yen
    Lee, Wen-Lieng
    Lin, Wei-Wen
    HEALTHCARE, 2024, 12 (21)
  • [33] Improving diabetic patients’ adherence to treatment and prevention of cardiovascular disease (Office Guidelines Applied to Practice—IMPACT Study)—a cluster randomized controlled effectiveness trial
    Adesuwa Olomu
    Karen Kelly-Blake
    William Hart-Davidson
    Joseph Gardiner
    Zhehui Luo
    Michele Heisler
    Margaret Holmes-Rovner
    Trials, 23
  • [34] Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study
    McConnachie, Alex
    Walker, Andrew
    Robertson, Michele
    Marchbank, Laura
    Peacock, Julie
    Packard, Christopher J.
    Cobbe, Stuart M.
    Ford, Ian
    EUROPEAN HEART JOURNAL, 2014, 35 (05) : 290 - 298
  • [35] Improving diabetic patients' adherence to treatment and prevention of cardiovascular disease (Office Guidelines Applied to Practice-IMPACT Study)-a cluster randomized controlled effectiveness trial
    Olomu, Adesuwa
    Kelly-Blake, Karen
    Hart-Davidson, William
    Gardiner, Joseph
    Luo, Zhehui
    Heisler, Michele
    Holmes-Rovner, Margaret
    TRIALS, 2022, 23 (01)
  • [36] Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) study
    Shoukat, Affan
    Bawden, Carolyn E.
    Rost, Gergely
    Leblanc, Jason J.
    Galvani, Alison P.
    Langley, Joanne M.
    Moghadas, Seyed M.
    VACCINE, 2024, 42 (07) : 1768 - 1776